Eva.J and Bioressant: Pioneering Swiss Neurocosmetics Through Scientific Innovation

In the sophisticated landscape of contemporary skincare, where scientific rigor meets holistic wellness, Swiss company Bioressant and its flagship brand Eva.J Swiss Organic Neurocosmetics stand as exemplars of innovation at the convergence of neuroscience, dermatology, and biotechnology. Founded by Eva Johnston in Lausanne, this pioneering enterprise has established itself as a trailblazer in the emerging field of neurocosmetics, leveraging Switzerland’s renowned scientific ecosystem and pristine Alpine biodiversity to create therapeutically-oriented skincare solutions.

 

 

Neurocosmetics: The Science of Skin-Brain Interaction

The skin and the nervous system are interconnected. Sensory neurons, like epidermal cells, form connections and secrete multiple substances that fuel a constant dialogue between the skin, the nervous system, and the immune system.
Neurocosmetics represents a revolutionary paradigm in skincare science, founded upon the intricate physiological interplay between the nervous system and cutaneous tissue. The concept, first defined by French Professor Laurent Misery in 2000, describes bio-active products that exhibit activity on the cutaneous nervous system while generating systemic effects through cutaneous mediators.
Eva.J’s formulations harness this bidirectional communication pathway, incorporating neuroactive ingredients that simultaneously address cutaneous inflammation, barrier dysfunction, and emotional well-being through sophisticated molecular mechanisms targeting microglial modulation and neurogenic regulation.

 

Patent-Protected Innovation

Bioressant’s product portfolio addresses a comprehensive spectrum of dermatological concerns, including adult acne, rosacea, premature aging, couperose, and post-treatment recovery. The company has also obtained two groundbreaking patents.

The first patent, awarded in November 2024, addresses the “Composition for the reduction of symptoms of couperose and/or rosacea,” representing a significant breakthrough in treating vascular skin conditions through neuromodulatory mechanisms. This innovation has been successfully integrated into the highly effective “Precious Scents and Colours for Face. Fragile Capillaries” serum.

The second patent, covering eight dermaceutical products designed for clinical and medical spa applications, focuses on delivering visible and long-lasting facial regeneration through synergistic formulations. These patented technologies target both peripheral and central nervous systems, regulating inflammatory responses while optimizing endogenous repair mechanisms. The resulting clinical outcomes demonstrate visibly healthier, more resilient, and less reactive skin, addressing the fundamental drivers of cutaneous disorders including chronic microinflammation, neurogenic disregulation, and compromised barrier function.

 

Nature’s treasures for healthy skin

Eva.J’s formulations embody the pinnacle of Swiss pharmaceutical precision, utilizing over 30 meticulously selected Alpine botanicals sourced from high-altitude cooperatives. examples of product and their ingredients acting in synergy.

Several studies demonstrate how components of certain essential oils and plant extracts can influence microglial connections and support neurological health:

1. Linalool – Found in Lavender, a major component of lavender, has been shown to reduce inflammation in microglial cells. Present in several products.

2. Alpha-Pinene – Found in Pine Oils.  Significantly reduces neuroinflammation and cellular stress in the hippocampus. Used used in the Fragile Capillaries Couperose Serum (patented formula)

3. Alchemilla (Lady’s Mantle) Extract, has demonstrated neuroprotective and anti-inflammatory properties, especially for sensitive skin and during periods of high physical stress. It is included in Cream N°3, formulated for sensitive skin, menopause, or recovery after significant physical effort.

 

Sustainable Swiss Excellence and Botanical Precision

« The company’s commits to sustainability extends throughout its entire value chain, with 68% of botanical ingredients originating from Valais, processed locally in Fribourg, and packaged through partnerships with Polyval Foundation, which supports professional integration for individuals with disabilities », explains Eva Johns.
This sustainable approach encompasses rigorous quality standards, ensuring that each plant extract maintains optimal therapeutic potency. Every formulation undergoes comprehensive testing for efficacy and safety, ensuring “swiss-made” quality while maintaining complete traceability from cultivation to consumer application. Uncompromised retail appeal driven by proven efficacy and long shelf life and stability—without the use of harsh chemical ingredients—earns the trust of today’s well-informed consumers and partners.

 

Future Horizons and Expansion

As the neurocosmetics sector experiences unprecedented growth, projected to reach USD 2.7 billion by 2030 with an 8.4% CAGR, Bioressant is strategically positioned to capitalize on this expanding market through continued research and development. The brand’s products are available through select pharmacies in Geneva, Vaud, and Bern, alongside professional-grade formulations distributed through medical clinics and spa facilities.

 

📸 © Bioressant. From L to R: Teun Wagenaar board member, Niels Rodin  et Eva Johnston (left – bottom), founder.